VISTN logo

Vistin Pharma ASA Stock Price

OB:VISTN Community·NOK 904.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

VISTN Share Price Performance

NOK 0
-24.80 (-100.00%)
NOK 0
-24.80 (-100.00%)
Price NOK 0

VISTN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and fair value.

2 Risks
1 Reward

Vistin Pharma ASA Key Details

NOK 449.5m

Revenue

NOK 150.2m

Cost of Revenue

NOK 299.3m

Gross Profit

NOK 224.7m

Other Expenses

NOK 74.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 20, 2026
1.68
66.59%
16.59%
0%
View Full Analysis

About VISTN

Founded
1969
Employees
76
CEO
Magnus Tolleshaug
WebsiteView website
www.vistin.com

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; metformin direct compressible; and metformin premixed with lubricant magnesium stearate for use in plain metformin immediate release tablets. The company was founded in 1969 and is based in Oslo, Norway.

Recent VISTN News & Updates

Recent updates

No updates